StonvexLoading…
StonvexStonvexStonvexCore line items from AVAV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $820.63M | $716.72M | $540.54M | $445.73M |
Operating Income | $40.80M | $71.82M | $-178.66M | $-9.89M |
Net Income | $43.62M | $59.67M | $-176.17M | $-4.18M |
EPS (Diluted) | $1.55 | $2.18 | $-7.04 | $-0.17 |
Total Assets | $1.12B | $1.02B | $824.58M | $914.20M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $40.86M | $73.30M | $132.86M | $77.23M |
Free Cash Flow OCF − CapEx | $-24.13M | $-7.69M | $-3.47M | $-31.91M |
Shares Outstanding | 28.27M | 28.13M | 26.22M | 24.95M |